Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross‐sectional analysis in Malaysia-Reference-Cited by-同舟云学术

Correlation of whole blood hydroxychloroquine concentration with cutaneous lupus erythematosus and factors associated with it: First multicenter, cross‐sectional analysis in Malaysia

Published:2022-01-24 Issue:5 Volume:49 Page:545-549
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Peh D.¹,Wan Ahmad Kammal W. S. L.¹²,Beh P. J.³,Yong A. C. H.³,Tan W. C.⁴,Lim A. L.⁵,Thevarajah S.⁶,Stanslas J.⁷,How Kang Nien¹²^ORCID

Affiliation:

1. Dermatology Unit Faculty of Medicine and Health Sciences Universiti Putra Malaysia Serdang Selangor Malaysia

2. Hospital Pengajar Universiti Putra Malaysia Serdang Selangor Malaysia

3. Faculty of Pharmacy MAHSA University Bandar Saujana Putra Selangor Malaysia

4. Department of Dermatology Hospital Pulau Pinang George Town Pulau Pinang Malaysia

5. Rheumatology Unit Department of Medicine Hospital Pulau Pinang George Town Pulau Pinang Malaysia

6. Department of Dermatology Hospital Kuala Lumpur Kuala Lumpur Malaysia

7. Pharmacotherapeutic Unit Faculty of Medicine and Health Sciences Universiti Putra Malaysia Selangor Malaysia

Funder

Universiti Putra Malaysia

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16292

Reference15 articles.

1. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)

2. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI)

3. Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus

4. The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study

5. Development of the CLASI as a Tool to Measure Disease Severity and Responsiveness to Therapy in Cutaneous Lupus Erythematosus

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?;Clinical and Experimental Medicine;2023-07-22